The Retinoblastoma-Histone Deacetylase 3 Complex Inhibits PPARγ and Adipocyte Differentiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Retinoblastoma-Histone Deacetylase 3 Complex Inhibits PPARγ and Adipocyte Differentiation

Published:2002-12 Issue:6 Volume:3 Page:903-910
ISSN:1534-5807
Container-title:Developmental Cell
language:en
Short-container-title:Developmental Cell

Author:

Fajas Lluis,Egler Viviane,Reiter Raphael,Hansen Jacob,Kristiansen Karsten,Debril Marie-Bernard,Miard Stéphanie,Auwerx Johan

Publisher

Elsevier BV

Subject

Developmental Biology,Cell Biology,General Biochemistry, Genetics and Molecular Biology,Molecular Biology

Reference30 articles.

1. Bonus, a Drosophila homolog of TIF1 proteins, interacts with nuclear receptors and can inhibit betaFTZ-F1-dependent transcription;Beckstead;Mol. Cell,2001

2. Retinoblastoma protein recruits histone deacetylase to repress transcription;Brehm;Nature,1998

3. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor;Cavailles;EMBO J.,1995

4. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs;Chen;Genes Dev.,1996

5. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs;Chen;Genes Dev.,1996

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bmi‐1 Epigenetically Orchestrates Osteogenic and Adipogenic Differentiation of Bone Marrow Mesenchymal Stem Cells to Delay Bone Aging;Advanced Science;2024-09-03

2. Impaired Remodeling of White Adipose Tissue in Obesity and Aging: From Defective Adipogenesis to Adipose Organ Dysfunction;Cells;2024-04-30

3. How mesenchymal stem cells transform into adipocytes: Overview of the current understanding of adipogenic differentiation;World Journal of Stem Cells;2024-03-26

4. Cell-state dependent regulation of PPAR_γsignaling by ZBTB9 in adipocytes;2024-03-06

5. Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator;Medical Oncology;2024-03-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3